UN Member States Briefed On Innovation And Access To Health Technologies 14/03/2018 by William New, Intellectual Property Watch Leave a Comment NEW YORK — A major event on innovation and access to health technologies took place at the United Nations in New York last week, in which UN member states were briefed on ideas and efforts to promote these issues at the forefront of global health policy.
Sir John Sulston, Human Genome Project Leader, Remembered For Words On IP And Health R&D 14/03/2018 by William New, Intellectual Property Watch Leave a Comment Nobel Prize winner Sir John Sulston passed away on 6 March at the age of 75, and was widely remembered in the press and scientific circles, celebrating his research, his wisdom, and his leadership of the landmark Human Genome Project. Intellectual Property Watch recalls his visionary warning and advice a decade ago about the intellectual property system, investment, and science that is still valuable today.
WHO: Access To Hepatitis C Treatment Increasing, But Most Patients Undiagnosed 13/03/2018 by Catherine Saez, Intellectual Property Watch 1 Comment Access to hepatitis C treatments is increasing, so are therapeutic options, but most of those living with the disease are not diagnosed and thus remain untreated, the World Health Organization found in a new report. Upper-middle income and high-income countries continue to pay high prices, impeding equitable access, and those countries which have been most successful in increasing access have mobilised a strong government response, the report found.
A Look At The Role Of Governments, Universities, Science In Health Innovation & Access 05/03/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment Intellectual property rights, particularly patents, are considered by some as being a barrier in access to medicines despite being a stimulus for innovation. At a recent symposium co-organised by the World Health Organization, World Trade Organization and World Intellectual Property Organization, speakers also talked about the role of science, governments, and universities in health innovation and access, and how to address challenges such as secondary patents.
WHO Joint Tropical Disease Program Issues Report On Research Fairness 02/03/2018 by Intellectual Property Watch Leave a Comment The World Health Organisation’s Special Programme for Research and Training in Tropical Diseases (TDR) has published the first report on research fairness under a new initiative. The report includes an analysis of how TDR manages intellectual property rights in a positive way.
Medicines Vastly Overpriced, Generics Too: Discussion At WTO-WIPO-WHO Symposium 02/03/2018 by Catherine Saez, Intellectual Property Watch 1 Comment The price of hepatitis C medicine marked a turning point in the discussion on access to medicines, with developed countries suddenly confronted to prices they could not afford. This week, a symposium jointly organised by the World Health Organization, the World Trade Organization, and the World Intellectual Property Organization explored the question of the pricing of medicines. A number of suggestions were made to alleviate the issue, such as ensuring wide use of generic medicines, encouraging competition, and alerting countries about the cost of medicine production so they negotiate better with pharmaceutical companies.
Study: TRIPS Flexibilities Widely Used By Countries, Contrary To Reports 02/03/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment Despite the widespread view that the flexibilities included in international trade rules are not often used, a new study found that countries make extensive use of those flexibilities.
Video Gaming Industry Issues Attack On WHO’s Proposed Gaming Disorder Classification 01/03/2018 by Intellectual Property Watch Leave a Comment Teens’ (and others’) life-altering obsession with video gaming is well-known to almost any parent in most countries around the world, and the World Health Organization recently identified it as an addiction called “gaming disorder.” Today, the self-acclaimed $36 billion video gaming industry hit back with a statement about a new paper from “preeminent researchers and scientists” that it says casts doubt on the WHO’s efforts.
WTO, WHO, WIPO Heads Share Views On Innovation And Access At Trilateral Symposium 27/02/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment How to encourage health innovations and make sure that new medicines, vaccines, or diagnostics will reach every person who needs them? That is a question which has been hotly debated in different fora. Yesterday, the World Trade Organization, UN World Health Organization, and UN World Intellectual Property Organization jointly held a symposium on how innovative technologies can promote the United Nations Sustainable Development Goals. The WHO director general called on his colleagues to support policies facilitating access to health technologies.
Swiss Panel Looks At Value-Based Drug Pricing, Link Between R&D And Prices 26/02/2018 by Catherine Saez and William New, Intellectual Property Watch Leave a Comment Some products are too cheap, generic drug companies do not invest in them because they do not make enough money out of them. Others seem astronomically expensive, and are said to include the costs of all research, successes and failures alike. Panellists at a recent Swiss-organised expert event in Bern concurred that something must done about pricing, and explored some surprising ways to do it.